297 related articles for article (PubMed ID: 10480326)
1. Selective antagonism of endothelin ET(A) or ET(B) receptor in renal hemodynamics and function of deoxycorticosterone acetate-salt-induced hypertensive rats.
Matsumura Y; Taira S; Kitano R; Hashimoto N; Kuro T
Biol Pharm Bull; 1999 Aug; 22(8):858-62. PubMed ID: 10480326
[TBL] [Abstract][Full Text] [Related]
2. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
[TBL] [Abstract][Full Text] [Related]
3. Endothelin ET(B) receptor-mediated action on systemic and renal hemodynamics and urine formation in deoxycorticosterone acetate-salt-induced hypertensive rats.
Hashimoto N; Kuro T; Fujita K; Azuma S; Matsumura Y
Biol Pharm Bull; 1998 Aug; 21(8):800-4. PubMed ID: 9743245
[TBL] [Abstract][Full Text] [Related]
4. Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension.
Johnson RJ; Galligan JJ; Fink GD
J Hypertens; 2001 Mar; 19(3):431-40. PubMed ID: 11288813
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
6. Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension.
Matsumura Y; Kuro T; Kobayashi Y; Konishi F; Takaoka M; Wessale JL; Opgenorth TJ; Gariepy CE; Yanagisawa M
Circulation; 2000 Nov; 102(22):2765-73. PubMed ID: 11094045
[TBL] [Abstract][Full Text] [Related]
7. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
Fujita K; Matsumura Y; Miyazaki Y; Hashimoto N; Takaoka M; Morimoto S
Life Sci; 1996; 58(1):PL1-7. PubMed ID: 8628104
[TBL] [Abstract][Full Text] [Related]
8. Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.
Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Ueda M; Tatsumi Y; Yoshikawa J
Metabolism; 1997 Sep; 46(9):1032-8. PubMed ID: 9284892
[TBL] [Abstract][Full Text] [Related]
9. Ameliorating effect of an endothelin ETA receptor antagonist on renal function of DOCA-salt hypertensive rats.
Matsumura Y; Hashimoto N; Fujita K; Morimoto S
Eur J Pharmacol; 1997 Jan; 319(1):65-9. PubMed ID: 9030899
[TBL] [Abstract][Full Text] [Related]
10. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
Allcock GH; Venema RC; Pollock DM
Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
[TBL] [Abstract][Full Text] [Related]
11. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
Johnson RJ; Fink GD; Watts SW; Galligan JJ
J Hypertens; 2002 Apr; 20(4):665-76. PubMed ID: 11910302
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
13. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
Fujita K; Matsumura Y; Kita S; Miyazaki Y; Hisaki K; Takaoka M; Morimoto S
Br J Pharmacol; 1995 Mar; 114(5):925-30. PubMed ID: 7780646
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats.
Pollock DM; Allcock GH; Krishnan A; Dayton BD; Pollock JS
Am J Physiol Renal Physiol; 2000 Feb; 278(2):F279-86. PubMed ID: 10662732
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
[TBL] [Abstract][Full Text] [Related]
16. Increased susceptibility to deoxycorticosterone acetate-salt-induced hypertension in endothelin-B-receptor-deficient rats.
Matsumura Y; Kuro T; Kobayashi Y; Konishi F; Takaoka M; Wessale JL; Opgenorth TJ; Gariepy CE; Yanagisawa M
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S86-9. PubMed ID: 11078344
[TBL] [Abstract][Full Text] [Related]
17. Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chung TH; Lin SZ; Chang NC
J Hypertens; 2014 Apr; 32(4):795-805. PubMed ID: 24463935
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
Watts SW; Fink GD; Northcott CA; Galligan JJ
Br J Pharmacol; 2002 Sep; 137(1):69-79. PubMed ID: 12183332
[TBL] [Abstract][Full Text] [Related]
19. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
Giulumian AD; Pollock DM; Clarke N; Fuchs LC
Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism.
Sharifi AM; Schiffrin EL
J Hypertens; 1997 Dec; 15(12 Pt 1):1441-8. PubMed ID: 9431850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]